So how does FDA review an ad? The public record offers some valuable insight, in the form of enforcement letters sent by the agency to sponsors. But the pickings are pretty thin in recent years, since ad letters came under the purview of the Office of the Chief Counsel. ( See "The New Era in DTC," in this issue Also see "The New Era in DTC: FDA Plans New Fees, Fines-and Creative Advice" - Pink Sheet, 1 October, 2007..)
The most recent warning letter issued for a full length TV ad came in June 2005, regarding Lilly’s ADHD therapy...




